Actual Medicinal Product (AMP) Exforge 5mg/160mg tablets (Novartis Pharmaceuticals UK Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Moisture sensitive medicine, store in airtight (sealed) MCA. Protect from light. No stability data in MCAs available
- Provenance
-
This recommendation is based on the products Exforge 5mg/160mg film-coated tablets (Novartis Pharmaceuticals UK Ltd) and Amlodipine/Valsartan 5mg/160mg film-coated tablets (Zentiva).
- Generic
- Amlodipine + Valsartan
- Formulation
- Amlodipine 5mg / Valsartan 160mg tablets
-
Amlodipine + Valsartan
-
Amlodipine 5mg / Valsartan 160mg tablets
-
Exforge 5mg/160mg tablets (Novartis Pharmaceuticals UK Ltd)
-
-